Cataracts in dogs occur for a variety of reasons, and can affect canines of every age. Breaking the news to a client that their beloved pet is losing his sight because of cataracts is never easy, partially because treatment options are so limited. Surgery, the “go-to” treatment, is not always practical or affordable for clients.
In the last few years, though, another treatment option — Lanosterol, a naturally-occurring molecule — has shown promise. A 2015 study published in Nature found that in both in vitro and cell-transfection tests, treatment with lanosterol dramatically reduced protein aggregates. It was also demonstrated that lanosterol therapy could lessen cataract severity in dogs and dissected rabbit cataractous lenses in vitro by increasing transparency.1
HOW LANOSTEROL WORKS
Mammals naturally produce lanosterol, a molecule that prevents the aligned crystallin proteins in the eye (which allow light to pass through to the retina) from deforming and aggregating into cloudy cataracts. Unfortunately, lanosterol is an insoluble molecule and could only be delivered to the aqueous environment of the eye via injection. Recently, though, one company has found a way to make lanosterol soluble, so it can be delivered to the lens via an easy-to-administer topical solution.
LumenoPro Veterinary Strength™ eye drops utilize this patent-pending process, and combine lanosterol with N-acetyl-carnosine (NAC), an antioxidant that scavenges for free radicals that cause tissue damage. LumenPro is the only commercially available eye drop that delivers both of these ingredients to the eye in a therapeutic dose. 
LumenPro is safe and effective, conforming to the monographs for over-the-counter eye drops published by the U.S. Food and Drug Administration. The ingredients have been thoroughly tested and proven to be effective in resolving cataracts in pets. LumenPro is also affordable and easy to apply, making it a practical solution for clients who are looking for an alternative to surgery for their dogs.
Join the study trial for cataracts in dogs
The team behind LumenPro Veterinary Strength™ eye drops is inviting veterinarians to participate in clinical observations of the effectiveness of LumenPro Veterinary Strength in patients. During the trial, participating clinics will receive free products for their enrolled subjects and financial reimbursement of their study-related time. LumenPro Veterinary Strength eye drops are exclusively available to veterinary clinics, where proper cataract screening, improved patient compliance, and regular follow-up visits can be better tracked. Contact LumenPro today to receive a free kit with more information on this study trial for cataracts in dogs, and other exclusive offers for participants.
References
1Zhao, L., Chen, XJ., Zhu, J. et al. Lanosterol reverses protein aggregation in cataracts. Nature 523, 607–611 (2015).https://doi.org/10.1038/nature14650
AUTHOR PROFILE
IVC Journal is a division of Redstone Media Group. Innovation is the key to veterinarians staying competitive and being able to provide their clients with the absolute best care possible. IVC Journal delivers the most up to date and compelling information available by bridging the gap between the traditional worlds of allopathic and integrative veterinary care.
